#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3436039	Functional	ST_JUDE_LEISH: Cytotoxicity against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro	Leishmania mexicana	791	ALA3433997	assay format	St Jude Leishmania Screening
2.	ALA3436040	Functional	ST_JUDE_LEISH: Cytotoxicity against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro	Leishmania mexicana	791	ALA3433997	assay format	St Jude Leishmania Screening
3.	ALA3436041	Functional	ST_JUDE_LEISH: Cytotoxicity against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro	Leishmania mexicana	791	ALA3433997	assay format	St Jude Leishmania Screening
4.	ALA1789905	Functional	NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence.	Plasmodium yoelii	4,416	ALA1789904	organism-based format	Novartis Malaria Screening
5.	ALA3392923	Functional	MMV: IC50 determined against P. falciparum Dd2-luc strain using a Malaria Sybr Green I Fluorescence assay. Starting conditions were 1% trophozoite synchronised parasites at 2% haematocrit. Fluorescence detection completed after 48hr incubation at 37 degrees C under 1% O2, 3% CO2 and balance N2.	Plasmodium falciparum	315	ALA3392922	organism-based format	MMV Malaria Box
6.	ALA1040691	Functional	NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay	Plasmodium falciparum	5,614	ALA1156829	organism-based format	Novartis Malaria Screening
7.	ALA1040692	Functional	NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay	Plasmodium falciparum	5,614	ALA1156829	organism-based format	Novartis Malaria Screening
8.	ALA1040693	Toxicity	NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)	Homo sapiens	5,614	ALA1156829	cell-based format	Novartis Malaria Screening
9.	ALA1040694	Functional	NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.		5,614	ALA1156829	assay format	Novartis Malaria Screening
10.	ALA2028070	Functional	MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration.	Plasmodium falciparum	315	ALA2028040	organism-based format	MMV Malaria Box
11.	ALA2028071	Functional	MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).	Plasmodium falciparum	317	ALA2028040	organism-based format	MMV Malaria Box
12.	ALA2028072	Functional	MMV: Inhibition of Plasmodium falciparum K1 (EC50).	Plasmodium falciparum	171	ALA2028040	organism-based format	MMV Malaria Box
13.	ALA2028073	Functional	MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).	Trypanosoma cruzi	400	ALA2028040	organism-based format	MMV Malaria Box
14.	ALA2028074	Functional	MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).	Trypanosoma brucei brucei	400	ALA2028040	organism-based format	MMV Malaria Box
15.	ALA2028075	Functional	MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).	Trypanosoma brucei rhodesiense	400	ALA2028040	organism-based format	MMV Malaria Box
16.	ALA2028076	Functional	MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.	Leishmania infantum	400	ALA2028040	organism-based format	MMV Malaria Box
17.	ALA2028077	Toxicity	MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.	Homo sapiens	400	ALA2028040	cell-based format	MMV Malaria Box
18.	ALA2094261	Functional	MMV: Screen against Mtb, single point, non replicating, at 25uM	Mycobacterium tuberculosis	399	ALA2094260	organism-based format	MMV Malaria Box
19.	ALA2094262	Functional	MMV: Screen against Mtb, single point, replicating, at 25uM	Mycobacterium tuberculosis	399	ALA2094260	organism-based format	MMV Malaria Box
20.	ALA2363023	Functional	MMV: Toxicity @ 2.5 uM to newly transformed Schistosoma mansoni somules after 24 h on a scale of 0 (none) - 4 (most) as judged visually: includes short descriptors of effects (PMID:19597541). Caffrey group UCSF.	Schistosoma mansoni	400	ALA2363022	organism-based format	MMV Malaria Box